Literature DB >> 28408421

Modeling CBL activating mutations in vivo.

Stanley Chun-Wei Lee1, Omar Abdel-Wahab1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28408421      PMCID： PMC5391629          DOI： 10.1182/blood-2017-03-770222

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  Altered thymic positive selection and intracellular signals in Cbl-deficient mice.

Authors:  M Naramura; H K Kole; R J Hu; H Gu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Acquired expression of CblQ367P in mice induces dysplastic myelopoiesis mimicking chronic myelomonocytic leukemia.

Authors:  Yuichiro Nakata; Takeshi Ueda; Akiko Nagamachi; Norimasa Yamasaki; Ken-Ichiro Ikeda; Yasuyuki Sera; Keiyo Takubo; Akinori Kanai; Hideaki Oda; Masashi Sanada; Seishi Ogawa; Kohichiro Tsuji; Yasuhiro Ebihara; Linda Wolff; Zen-Ichiro Honda; Toshio Suda; Toshiya Inaba; Hiroaki Honda
Journal:  Blood       Date:  2017-02-16       Impact factor: 22.113

3.  Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling.

Authors:  Chozhavendan Rathinam; Christine B F Thien; Richard A Flavell; Wallace Y Langdon
Journal:  Cancer Cell       Date:  2010-10-19       Impact factor: 31.743

4.  Mutations of e3 ubiquitin ligase cbl family members constitute a novel common pathogenic lesion in myeloid malignancies.

Authors:  Hideki Makishima; Heather Cazzolli; Hadrian Szpurka; Andrew Dunbar; Ramon Tiu; Jungwon Huh; Hideki Muramatsu; Christine O'Keefe; Eric Hsi; Ronald L Paquette; Seiji Kojima; Alan F List; Mikkael A Sekeres; Michael A McDevitt; Jaroslaw P Maciejewski
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

5.  Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms.

Authors:  Masashi Sanada; Takahiro Suzuki; Lee-Yung Shih; Makoto Otsu; Motohiro Kato; Satoshi Yamazaki; Azusa Tamura; Hiroaki Honda; Mamiko Sakata-Yanagimoto; Keiki Kumano; Hideaki Oda; Tetsuya Yamagata; Junko Takita; Noriko Gotoh; Kumi Nakazaki; Norihiko Kawamata; Masafumi Onodera; Masaharu Nobuyoshi; Yasuhide Hayashi; Hiroshi Harada; Mineo Kurokawa; Shigeru Chiba; Hiraku Mori; Keiya Ozawa; Mitsuhiro Omine; Hisamaru Hirai; Hiromitsu Nakauchi; H Phillip Koeffler; Seishi Ogawa
Journal:  Nature       Date:  2009-07-20       Impact factor: 49.962

6.  Mutations in CBL occur frequently in juvenile myelomonocytic leukemia.

Authors:  Mignon L Loh; Debbie S Sakai; Christian Flotho; Michelle Kang; Manfred Fliegauf; Sophie Archambeault; Charles G Mullighan; Leslie Chen; Eva Bergstraesser; Carlos E Bueso-Ramos; Peter D Emanuel; Henrik Hasle; Jean-Pierre Issa; Marry M van den Heuvel-Eibrink; Franco Locatelli; Jan Stary; Monica Trebo; Marcin Wlodarski; Marco Zecca; Kevin M Shannon; Charlotte M Niemeyer
Journal:  Blood       Date:  2009-07-01       Impact factor: 22.113

7.  The E3 ubiquitin ligase c-Cbl restricts development and functions of hematopoietic stem cells.

Authors:  Chozhavendan Rathinam; Christine B F Thien; Wallace Y Langdon; Hua Gu; Richard A Flavell
Journal:  Genes Dev       Date:  2008-04-15       Impact factor: 11.361

Review 8.  An evolutionary perspective on chronic myelomonocytic leukemia.

Authors:  R Itzykson; E Solary
Journal:  Leukemia       Date:  2013-04-05       Impact factor: 11.528

9.  A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase.

Authors:  Christine B F Thien; Robin M Scaife; John M Papadimitriou; Maria A Murphy; David D L Bowtell; Wallace Y Langdon
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

10.  Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness.

Authors:  Natacha Bohin; Tiffany Wen; Qing Li; Victor Ng; Jeffrey Magee; Shann-Ching Chen; Kevin Shannon; Sean J Morrison
Journal:  Nature       Date:  2013-11-27       Impact factor: 49.962
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.